Abbreviation | Full Name | Site of Action* |
---|---|---|
αβmADP | Adenosine 5'-(α,β-methylene)diphosphate | Ecto-5'-nucleotidase inhibitor |
Adenosine | 9-β-D-Ribofuranosyladenine | Nonselective adenosine receptor agonist |
ATP | Adenosine 5'-triphosphate | P2 purinergic agonist |
BBG | Brilliant blue G | P2X7 receptor antagonist |
BzATP | 2'(3')-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate triethylammonium salt | P2X purinergic agonist; more potent than ATP at P2X7 receptors |
CGS-21680 | 4-[2-[[6-Amino-9-(N-ethyl-b-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropanoic acid hydrochloride | A2A adenosine receptor agonist |
Dipyridamole | 2,6-Bis(Diethanolamino)-4,8-dipiperidinopyrimido [5,4-d] pyrimidine | Equlibrative nucleoside transporter inhibitor |
IB-MECA | 1-Deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-y l]-N-methyl-b-D-ribofuranuronamide | Selective A3 adenosine receptor agonist |
2'MeCCPA | 2-Chloro-N-cyclopentyl-2'-methyladenosine | Selective A1 adenosine receptor agonist |
MRS 1754 | N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide | Selective adenosine A2B receptor antagonist |
NBMPR | S-(4-Nitrobenzyl)-6-thioinosine | Equilibrative nucleoside transporter 1 inhibitor |
NECA | 5'-N-ethylcarboxamidoadenosine | Nonselective adenosine receptor agonist. |
Phloridzin | Phloretin 2'-β-D-glucopyranoside | Concentrative nucleoside transporter inhibitor |
PSB 603 | 8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine | Selective adenosine A2B receptor antagonist |
Suramin | 8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-me thyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalene trisulfonic acid hexasodium salt | P2 antagonist (with broad subtype selectivity) |
UTP | Uridine 5'-triphosphate | P2Y2/P2Y4 receptor agonist |